0000950170-24-026625.txt : 20240305
0000950170-24-026625.hdr.sgml : 20240305
20240305200618
ACCESSION NUMBER: 0000950170-24-026625
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240301
FILED AS OF DATE: 20240305
DATE AS OF CHANGE: 20240305
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: KAKKIS EMIL D
CENTRAL INDEX KEY: 0001248093
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36276
FILM NUMBER: 24723821
MAIL ADDRESS:
STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC.
STREET 2: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc.
CENTRAL INDEX KEY: 0001515673
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 272546083
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
BUSINESS PHONE: 415-483-8800
MAIL ADDRESS:
STREET 1: 60 LEVERONI COURT
CITY: NOVATO
STATE: CA
ZIP: 94949
4
1
ownership.xml
4
X0508
4
2024-03-01
0001515673
Ultragenyx Pharmaceutical Inc.
RARE
0001248093
KAKKIS EMIL D
C/O ULTRAGENYX PHARMACEUTICAL INC.
60 LEVERONI COURT
NOVATO
CA
94949
true
true
false
false
President & CEO
false
Common Stock
2024-03-01
4
A
false
38428
0
A
578198
D
Common Stock
2024-03-01
4
F
false
17417
53.69
D
560781
D
Common Stock
2024-03-01
4
A
false
3132
0
A
563913
D
Common Stock
2263985
I
See FN
Stock Option (Right to Buy)
53.69
2024-03-01
4
A
false
70094
0
A
2034-03-01
Common Stock
70094
70094
D
Award of Restricted Stock Units ("RSUs") under the Company's 2023 Incentive Plan. The RSUs shall vest with respect to 1/4th of the underlying shares on each anniversary of the grant date, such that the RSUs are fully vested on the fourth anniversary of the grant date
Represents shares surrendered to the Issuer by the Reporting Person to pay required tax withholdings due to the vesting of RSUs.
Represents shares of common stock which previously granted performance stock units were converted on March 1, 2024 upon certification of the performance metric.
Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions.
By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009
On the first anniversary of the grant date of the option (the "Option Anniversary Date"), 1/4th of the shares initially subject to the option shall vest; thereafter, 1/48th of the shares initially subject to the option shall vest on each month as measured from the Option Anniversary Date.
/s/ Karah Parschauer, attorney-in-fact
2024-03-05